oxazoles has been researched along with Demyelinating Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hu, J; Jin, J; Wang, X; Xiao, Q; Xue, N; Yin, D; Zhou, W | 1 |
| Bertolotto, A; Finardi, A; Furlan, R; Hintermann, S; Martire, S; Montarolo, F; Perga, S; Raffaele, C | 1 |
2 other study(ies) available for oxazoles and Demyelinating Diseases
| Article | Year |
|---|---|
Development of a selective S1P1 receptor agonist, Syl930, as a potential therapeutic agent for autoimmune encephalitis.
Topics: Animals; Area Under Curve; Brain; Brain Diseases; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Demyelinating Diseases; Encephalitis; Encephalomyelitis, Autoimmune, Experimental; Endocytosis; Female; Hashimoto Disease; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphocytes; Male; Microscopy, Confocal; Molecular Structure; Oxazoles; Propanolamines; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Spinal Cord | 2014 |
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Axons; Cell Count; Demyelinating Diseases; Down-Regulation; Encephalomyelitis, Autoimmune, Experimental; Female; Isoxazoles; Macrophages; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 2; Oxazoles; Peptide Fragments; Pyrimidinones; Signal Transduction; Spinal Cord; T-Lymphocytes | 2014 |